Application of Peptide-Conjugated Photosensitizers for Photodynamic Cancer Therapy: A Review

References (111)

1. 1 Bartusik-Aebisher, D., Woźnicki, P., Dynarowicz, K., and Aebisher, D. (2023). Photosensitizers for Photodynamic Therapy of Brain Cancers—A Review. Brain Sci., 13. [DOI]
2. 2 Gilaberte, 2023, Photodynamic Therapy, a successful treatment for granular parakeratosis [DOI]
3. 3 Ibarra, 2023, Photodynamic therapy in cancer stem cells-state of the art [DOI]
4. 4 Kolarikova, 2023, Photodynamic therapy: Innovative approaches for antibacterial and anticancer treatments [DOI]
5. 5 Mosaddad, 2023, Photodynamic Therapy in Oral Cancer: A Narrative Review [DOI]
6. 6 Van Straten, D., Mashayekhi, V., De Bruijn, H., Oliveira, S., and Robinson, D. (2017). Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions. Cancers, 9. [DOI]
7. 7 Calixto, G., Bernegossi, J., De Freitas, L., Fontana, C., and Chorilli, M. (2016). Nanotechnology-Based Drug Delivery Systems for Photodynamic Therapy of Cancer: A Review. Molecules, 21. [DOI]
8. 8 Castano, 2005, Mechanisms in photodynamic therapy: Part two—Cellular signaling, cell metabolism and modes of cell death [DOI]
9. 9 Hempstead, 2015, Low-cost photodynamic therapy devices for global health settings: Characterization of battery-powered LED performance and smartphone imaging in 3D tumor models [DOI]
10. 10 Huis In ‘T Veld, R.V., Heuts, J., Ma, S., Cruz, L.J., Ossendorp, F.A., and Jager, M.J. (2023). Current Challenges and Opportunities of Photodynamic Therapy against Cancer. Pharmaceutics, 15. [DOI]
11. 11 Kim, 2020, Light Sources and Dosimetry Techniques for Photodynamic Therapy [DOI]
12. 12 Morton, 2008, Guidelines for topical photodynamic therapy: Update [DOI]
13. 13 Plaetzer, 2009, Photophysics and photochemistry of photodynamic therapy: Fundamental aspects [DOI]
14. 14 Robertson, 2009, Photodynamic therapy (PDT): A short review on cellular mechanisms and cancer research applications for PDT [DOI]
15. 15 Correia, J.H., Rodrigues, J.A., Pimenta, S., Dong, T., and Yang, Z. (2021). Photodynamic Therapy Review: Principles, Photosensitizers, Applications, and Future Directions. Pharmaceutics, 13. [DOI]
16. 16 Kataoka, 2017, New photodynamic therapy with next-generation photosensitizers [DOI]
17. 17 Yano, 2011, Current states and future views in photodynamic therapy [DOI]
18. 18 Jiang, W., Liang, M., Lei, Q., Li, G., and Wu, S. (2023). The Current Status of Photodynamic Therapy in Cancer Treatment. Cancers, 15. [DOI]
19. 19 Sapio, L., and Naviglio, S. (2022). Innovation through Tradition: The Current Challenges in Cancer Treatment. Int. J. Mol. Sci., 23. [DOI]
20. 20 Kim, T.E., and Chang, J.-E. (2023). Recent Studies in Photodynamic Therapy for Cancer Treatment: From Basic Research to Clinical Trials. Pharmaceutics, 15. [DOI]
21. 21 Ethirajan, 2011, The role of porphyrin chemistry in tumor imaging and photodynamic therapy [DOI]
22. 22 Gunaydin, 2021, Photodynamic Therapy for the Treatment and Diagnosis of Cancer–A Review of the Current Clinical Status [DOI]
23. 23 Lima, E., and Reis, L.V. (2023). Photodynamic Therapy: From the Basics to the Current Progress of N-Heterocyclic-Bearing Dyes as Effective Photosensitizers. Molecules, 28. [DOI]
24. 24 Dias, 2021, Features of third generation photosensitizers used in anticancer photodynamic therapy: Review [DOI]
25. 25 Lovell, 2010, Activatable photosensitizers for imaging and therapy [DOI]
26. 26 Kwiatkowski, 2018, Photodynamic therapy - mechanisms, photosensitizers and combinations [DOI]
27. 27 Bilici, 2021, Recent Advances in Cyanine-Based Phototherapy Agents [DOI]
28. 28 Mallidi, 2016, Beyond the Barriers of Light Penetration: Strategies, Perspectives and Possibilities for Photodynamic Therapy [DOI]
29. 29 Shindy, 2017, Fundamentals in the chemistry of cyanine dyes: A review [DOI]
30. 30 Yuan, 2020, Activatable Photosensitizer for Smart Photodynamic Therapy Triggered by Reactive Oxygen Species in Tumor Cells [DOI]
31. 31 Jain, R., Mohanty, S., Sarode, I., Biswas, S., Singhvi, G., and Dubey, S.K. (2023). Multifunctional Photoactive Nanomaterials for Photodynamic Therapy against Tumor: Recent Advancements and Perspectives. Pharmaceutics, 15. [DOI]
32. 32 Forbes, J., and Krishnamurthy, K. (2024). Biochemistry, Peptide. StatPearls, StatPearls Publishing LLC.
33. 33 Barman, 2023, Strategic Approaches to Improvise Peptide Drugs as Next Generation Therapeutics [DOI]
34. 34 Lee, A.C.-L., Harris, J.L., Khanna, K.K., and Hong, J.-H. (2019). A Comprehensive Review on Current Advances in Peptide Drug Development and Design. Int. J. Mol. Sci., 20. [DOI]
35. 35 Luong, 2020, Antimicrobial peptides - Advances in development of therapeutic applications [DOI]
36. 36 Mukherjee, 2023, Evolving strategies and application of proteins and peptide therapeutics in cancer treatment [DOI]
37. 37 Wang, 2022, Therapeutic peptides: Current applications and future directions [DOI]
38. 38 Xie, 2020, Anti-cancer peptides: Classification, mechanism of action, reconstruction and modification [DOI]
39. 39 Xu, 2023, Penetrating peptides: Applications in drug delivery [DOI]
40. 40 Zhou, 2022, The role of cell-penetrating peptides in potential anti-cancer therapy [DOI]
41. 41 Al Musaimi, O., Lombardi, L., Williams, D.R., and Albericio, F. (2022). Strategies for Improving Peptide Stability and Delivery. Pharmaceuticals, 15. [DOI]
42. 42 Bruno, 2013, Basics and Recent Advances in Peptide and Protein Drug Delivery [DOI]
43. 43 Rossino, G., Marchese, E., Galli, G., Verde, F., Finizio, M., Serra, M., Linciano, P., and Collina, S. (2023). Peptides as Therapeutic Agents: Challenges and Opportunities in the Green Transition Era. Molecules, 28. [DOI]
44. 44 Li, 2022, Peptide-based supramolecular photodynamic therapy systems: From rational molecular design to effective cancer treatment [DOI]
45. 45 2022, Biochemical Basis of Selective Accumulation and Targeted Delivery of Photosensitizers to Tumor Tissues
46. 46 Schneider, 2006, Recent improvements in the use of synthetic peptides for a selective photodynamic therapy [DOI]
47. 47 Zhao, 2023, Assembled Photosensitizers Applied for Enhanced Photodynamic Therapy [DOI]
48. 48 Sun, 2022, Responsive Peptide Nanofibers with Theranostic and Prognostic Capacity [DOI]
49. 49 Sehgal, 2008, Photoinduced cytotoxicity and biodistribution of prostate cancer cell-targeted porphyrins [DOI]
50. 50 Nikoloudakis, 2019, A self-assembly study of PNA–porphyrin and PNA–BODIPY hybrids in mixed solvent systems [DOI]
51. 51 Wu, 2017, Zwitterionic stealth peptide-capped 5-aminolevulinic acid prodrug nanoparticles for targeted photodynamic therapy [DOI]
52. 52 Fan, 2020, A 64Cu-porphyrin-based dual-modal molecular probe with integrin αvβ3 targeting function for tumour imaging [DOI]
53. 53 Lucente, 2018, Novel 64Cu Labeled RGD2-BBN Heterotrimers for PET Imaging of Prostate Cancer [DOI]
54. 54 Marco, 2022, Multi-Targeting Approach of αvβ3 Integrin Ligands and their Applications in Diagnostic Field and Cancer Therapy
55. 55 Cho, 2020, Injectable Single-Component Peptide Depot: Autonomously Rechargeable Tumor Photosensitization for Repeated Photodynamic Therapy [DOI]
56. 56 Li, 2018, cRGD Peptide-Conjugated Pyropheophorbide-a Photosensitizers for Tumor Targeting in Photodynamic Therapy [DOI]
57. 57 Yan, 2021, CD133 peptide-conjugated pyropheophorbide-a as a novel photosensitizer for targeted photodynamic therapy in colorectal cancer stem cells [DOI]
58. 58 Zhang, 2022, Phototherapeutic effect of transformable peptides containing pheophorbide a on colorectal cancer [DOI]
59. 59 Abbas, 2017, Self-Assembled Peptide- and Protein-Based Nanomaterials for Antitumor Photodynamic and Photothermal Therapy [DOI]
60. 60 Kim, 2020, Peptide 18-4/chlorin e6-conjugated polyhedral oligomeric silsesquioxane nanoparticles for targeted photodynamic therapy of breast cancer [DOI]
61. 61 Liu, 2016, Simple Peptide-Tuned Self-Assembly of Photosensitizers towards Anticancer Photodynamic Therapy [DOI]
62. 62 Torkhovskaya, 2021, Chlorin e6 embedded in phospholipid nanoparticles equipped with specific peptides: Interaction with tumor cells with different aminopeptidase N expression [DOI]
63. 63 Kamarulzaman, 2015, New Peptide-Conjugated Chlorin-Type Photosensitizer Targeting Neuropilin-1 for Anti-Vascular Targeted Photodynamic Therapy [DOI]
64. 64 Thomas, 2009, Peptide-conjugated chlorin-type photosensitizer binds neuropilin-1 in vitro and in vivo [DOI]
65. 65 Li, 2019, Photodynamic therapy based on organic small molecular fluorescent dyes [DOI]
66. 66 Liu, 2018, Potent peptide-conjugated silicon phthalocyanines for tumor photodynamic therapy [DOI]
67. 67 Ongarora, 2012, Phthalocyanine-peptide conjugates for epidermal growth factor receptor targeting [DOI]
68. 68 Park, 2017, Photodynamic therapy by conjugation of cell-penetrating peptide with fluorochrome [DOI]
69. 69 Ser, 2020, Enhanced Efficacy of Photodynamic Therapy by Coupling a Cell-Penetrating Peptide with Methylene Blue [DOI]
70. 70 Dhillon, 2020, Rose Bengal-Amphiphilic Peptide Conjugate for Enhanced Photodynamic Therapy of Malignant Melanoma [DOI]
71. 71 Dhaini, B., Wagner, L., Moinard, M., Daouk, J., Arnoux, P., Schohn, H., Schneller, P., Acherar, S., Hamieh, T., and Frochot, C. (2022). Importance of Rose Bengal Loaded with Nanoparticles for Anti-Cancer Photodynamic Therapy. Pharmaceuticals, 15. [DOI]
72. 72 Langel, Ü. (2021). Cell-Penetrating Peptides and Transportan. Pharmaceutics, 13. [DOI]
73. 73 Raucher, 2015, Cell-penetrating peptides: Strategies for anticancer treatment [DOI]
74. 74 Huang, 2024, Cellular Uptake of Cell-Penetrating Peptides Activated by Amphiphilic p-Sulfonatocalix[4]arenes [DOI]
75. 75 Joliot, 1991, Antennapedia homeobox peptide regulates neural morphogenesis [DOI]
76. 76 Park, 2002, Mutational analysis of a human immunodeficiency virus type 1 Tat protein transduction domain which is required for delivery of an exogenous protein into mammalian cells [DOI]
77. 77 Dowaidar, 2024, Uptake pathways of cell-penetrating peptides in the context of drug delivery, gene therapy, and vaccine development [DOI]
78. 78 Mueller, 2008, Comparison of cellular uptake using 22 CPPs in 4 different cell lines [DOI]
79. 79 Koren, 2012, Cell-penetrating peptides: Breaking through to the other side [DOI]
80. 80 Przysiecka, 2015, Viral and other cell-penetrating peptides as vectors of therapeutic agents in medicine [DOI]
81. 81 Derakhshankhah, 2018, Cell penetrating peptides: A concise review with emphasis on biomedical applications [DOI]
82. 82 Rusiecka, 2022, Cell-penetrating peptides improve pharmacokinetics and pharmacodynamics of anticancer drugs [DOI]
83. 83 Afratis, 2012, Glycosaminoglycans: Key players in cancer cell biology and treatment [DOI]
84. 84 Zalba, 2017, Cell membrane modulation as adjuvant in cancer therapy [DOI]
85. 85 Li, C.M., Haratipour, P., Lingeman, R.G., Perry, J.J.P., Gu, L., Hickey, R.J., and Malkas, L.H. (2021). Novel Peptide Therapeutic Approaches for Cancer Treatment. Cells, 10. [DOI]
86. 86 Alves, 2014, A proapoptotic peptide conjugated to penetratin selectively inhibits tumor cell growth [DOI]
87. 87 Aroui, 2009, Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231 [DOI]
88. 88 Aroui, 2009, Conjugation of doxorubicin to cell penetrating peptides sensitizes human breast MDA-MB 231 cancer cells to endogenous TRAIL-induced apoptosis [DOI]
89. 89 Aroui, 2010, Cytotoxicity, intracellular distribution and uptake of doxorubicin and doxorubicin coupled to cell-penetrating peptides in different cell lines: A comparative study [DOI]
90. 90 Lopes, 2016, Transportan in nanocarriers improves skin localization and antitumor activity of paclitaxel [DOI]
91. 91 Wang, 2006, Synthesis and biological activity of conjugates between paclitaxel and the cell delivery vector penetratin [DOI]
92. 92 Lelle, 2014, Novel cleavable cell-penetrating peptide-drug conjugates: Synthesis and characterization [DOI]
93. 93 Nakase, 2012, Accumulation of arginine-rich cell-penetrating peptides in tumors and the potential for anticancer drug delivery in vivo [DOI]
94. 94 Zhang, 2006, siRNA-containing liposomes modified with polyarginine effectively silence the targeted gene [DOI]
95. 95 Singh, 2021, Intracellular delivery of oxaliplatin conjugate via cell penetrating peptide for the treatment of colorectal carcinoma in vitro and in vivo [DOI]
96. 96 Biswas, 2013, Octa-arginine-modified pegylated liposomal doxorubicin: An effective treatment strategy for non-small cell lung cancer [DOI]
97. 97 Liu, 2014, Paclitaxel loaded liposomes decorated with a multifunctional tandem peptide for glioma targeting [DOI]
98. 98 Koshkaryev, 2013, Bleomycin in octaarginine-modified fusogenic liposomes results in improved tumor growth inhibition [DOI]
99. 99 Shi, 2012, Enhancing cellular uptake of activable cell-penetrating peptide-doxorubicin conjugate by enzymatic cleavage
100. 100 Gao, 2013, Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides [DOI]
101. 101 Leng, 2015, Transactivator of transcription (TAT) peptide-chitosan functionalized multiwalled carbon nanotubes as a potential drug delivery vehicle for cancer therapy [DOI]
102. 102 Fales, 2013, Cell-penetrating peptide enhanced intracellular Raman imaging and photodynamic therapy [DOI]
103. 103 Song, 2015, Cell penetrating peptide TAT can kill cancer cells via membrane disruption after attachment of camptothecin [DOI]
104. 104 Taki, 2012, Intranasal Delivery of Camptothecin-Loaded Tat-Modified Nanomicells for Treatment of Intracranial Brain Tumors [DOI]
105. 105 Lakkadwala, 2020, Biodistribution of TAT or QLPVM coupled to receptor targeted liposomes for delivery of anticancer therapeutics to brain in vitro and in vivo [DOI]
106. 106 Tseng, 2002, Translocation of liposomes into cancer cells by cell-penetrating peptides penetratin and tat: A kinetic and efficacy study [DOI]
107. 107 Fang, 2013, A novel cell-penetrating peptide TAT-A1 delivers siRNA into tumor cells selectively [DOI]
108. 108 Tints, 2014, LXXLL Peptide Converts Transportan 10 to a Potent Inducer of Apoptosis in Breast Cancer Cells [DOI]
109. 109 Yamada, 2016, p28-Mediated Activation of p53 in G2–M Phase of the Cell Cycle Enhances the Efficacy of DNA Damaging and Antimitotic Chemotherapy [DOI]
110. 110 Thomas, 2020, Thermally Targeted p50 Peptide Inhibits Proliferation and Induces Apoptosis of Breast Cancer Cell Lines [DOI]
111. 111 Vale, N., Ribeiro, E., Cruz, I., Stulberg, V., Koksch, B., and Costa, B. (2023). New Perspective for Using Antimicrobial and Cell-Penetrating Peptides to Increase Efficacy of Antineoplastic 5-FU in Cancer Cells. J. Funct. Biomater., 14. [DOI]

Cited by 14

Showing 6 of 14 known citations — external sources report more than can currently be individually listed.

Related research

• Does Pain Adversely Affect the Quality of Life in Hospitalized Cancer Patients? — shares topic coverage
• Complementary Medicine Intervention in Breast Cancer Patients with Pain — shares topic coverage
• Use of Performance Status Score for Cytotoxic Chemotherapy among Surgeons in a Tertiary Hospital, Southern Nigeria — shares topic coverage
• Breast Self Examination and Cancer Awareness among Female Staff in Federal Medical Center, Yenagoa, Bayelsa State (Knowledge and Practice) — shares topic coverage
• Assessment of Cancer Risk from Fluorscopic Bile Duct Examinations at Sanjiwani Hospital, Gianyar — shares topic coverage